Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Zhaohui Zhu
Affiliation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
ORCID
Career Start Year
2000
Papers
190
H Index
34
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36328486
A Single-Arm, Low-Dose, Prospective Study of <sup>177</sup>Lu-EB-PSMA Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
J Nucl Med
2023
37284441
Dual targeting PET tracer [<sup>68</sup>Ga]Ga-FAPI-RGD in patients with lung neoplasms: a pilot exploratory study.
Theranostics
2023
37075254
Evaluation of Safety, Biodistribution, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177 Lu-DOTA-EB-TATE With and Without Amino Acid Infusion.
Clin Nucl Med
2023
37233785
A prospective head-to-head comparison of [<sup>68</sup>Ga]Ga-P16-093 and [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer.
Eur J Nucl Med Mol Imaging
2023
36723881
Peptide Receptor Radionuclide Therapy in Patients With Advanced Progressive Medullary Thyroid Cancer: Efficacy, Safety, and Survival Predictors.
Clin Nucl Med
2023
36477400
The role of [<sup>99m</sup>Tc]Tc-HFAPi SPECT/CT in patients with malignancies of digestive system: first clinical experience.
Eur J Nucl Med Mol Imaging
2023
36847364
Clinical Application of 24 G Cannula Needle and 3-0 Polypropylene Suture in Vas Deferens Exploration.
J Vis Exp
2023
36469068
68Ga-DOTATATE PET/CT of ACTH-Independent Cushing Syndrome Due to Ectopic Adrenocortical Adenoma.
Clin Nucl Med
2023
36600099
Head-to-head comparison of [<sup>68</sup>Ga]Ga-P16-093 and 2-[<sup>18</sup>F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study.
Eur J Nucl Med Mol Imaging
2023
36631812
Molecular imaging of HER2 expression in breast cancer patients using a novel peptide-based tracer <sup>99m</sup>Tc-HP-Ark2: a pilot study.
J Transl Med
2023
36892787
Effect of Selective Dorsal Neurectomy on Erectile Function in Rats.
Curr Med Sci
2023
34269727
Portal Biliopathy and Cavernous Transformation of the Portal Vein Revealed by 68Ga-FAPI PET/CT.
Clin Nucl Med
2022
35720018
A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of <sup>68</sup>Ga-NOTA-PRGD2 and <sup>18</sup>F-FDG PET/CT for Differentiating Benign and Malignant Pulmonary Space-Occupying Lesions.
Front Oncol
2022
35657429
A prospective head-to-head comparison of <sup>68</sup>Â Ga-NOTA-3P-TATE-RGD and <sup>68</sup>Â Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours.
Eur J Nucl Med Mol Imaging
2022
35984529
A pilot study of <sup>68</sup>Â Ga-PSMA-617 PET/CT imaging and <sup>177</sup>Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma.
EJNMMI Res
2022
36185603
Safety and efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors.
Theranostics
2022
34952347
Kit-based preparation of [<sup>68</sup>Ga]Ga-P16-093 (PSMA-093) using different commercial <sup>68</sup>Ge/<sup>68</sup>Ga generators.
Nucl Med Biol
2022
35265125
Somatostatin Treatment for Ectopic ACTH Syndrome due to Pancreatic Neuroendocrine Tumors: Review of the Literature.
Int J Endocrinol
2022
34557930
Head-to-head comparison of [<sup>68</sup>Â Ga]Ga-P16-093 and [<sup>68</sup>Â Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients.
Eur J Nucl Med Mol Imaging
2022
34570039
Site-based performance of 131I-MIBG imaging and 99mTc-HYNIC-TOC scintigraphy in the detection of nonmetastatic extra-adrenal paraganglioma.
Nucl Med Commun
2022
32826319
Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of <sup>177</sup>Lu-DOTA-EB-TATE.
J Nucl Med
2021
33656579
Correction to: <sup>68</sup>Ga-FAPI outperforms <sup>18</sup>F-FDG PET/CT in identifying solitary fibrous tumor.
Eur J Nucl Med Mol Imaging
2021
33741858
18F-FDG PET/CT imaging features of patients with multicentric Castleman disease.
Nucl Med Commun
2021
33517850
An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma.
Bioengineered
2021
33623136
Author Correction: The value of multiparameter <sup>18</sup>F-FDG PET/CT imaging in differentiating retroperitoneal paragangliomas from unicentric Castleman disease.
Sci Rep
2021
33512768
Prognostic impact of maximum standardized uptake value on <sup>18</sup> F-FDG PET/CT imaging of the primary lung lesion on survival in advanced non-small cell lung cancer: A retrospective study.
Thorac Cancer
2021
33927154
18F-FDG PET/computed tomography scan in patients with suspicion of recurrent neuroendocrine carcinoma of the cervix.
Nucl Med Commun
2021
33705970
Experience of Ectopic Adrenocorticotropin Syndrome: 88 Cases With Identified Causes.
Endocr Pract
2021
33529810
Safety and Effectiveness of Dapoxetine On Demand in Chinese Men With Premature Ejaculation: Results of a Multicenter, Prospective, Open-Label Phase IV Study.
Sex Med
2021
33632314
Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.
Cancer Imaging
2021
34619703
Prognostic Value of FDG PET/CT in Patients With Neuroendocrine Carcinoma of the Uterine Cervix.
Clin Nucl Med
2021
34076256
Ga-68 EDTA aerosols in evaluation of inhaled-particle deposition and clearance of obstructive pulmonary diseases: A pilot prospective study compared with Galligas.
Eur J Clin Invest
2021
34146130
Head-to-head comparison of <sup>68</sup>Ga-DOTATATE PET/CT and <sup>18</sup>F-FDG PET/CT in localizing tumors with ectopic adrenocorticotropic hormone secretion: a prospective study.
Eur J Nucl Med Mol Imaging
2021
34169423
Influencing Factors for Erectile Dysfunction of Young Adults with No Response to PDE5i.
Curr Med Sci
2021
34134735
<sup>68</sup>Ga-NOTA-Evans Blue PET/CT findings in lymphangioleiomyomatosis compared with <sup>99m</sup>TC-ASC lymphoscintigraphy: a prospective study.
Orphanet J Rare Dis
2021
33433603
Retraction: Down-regulation of microRNA-26b modulate non-small cell lung cancer cells chemoresistance and migration through the association of PTEN.
Acta Biochim Biophys Sin (Shanghai)
2021
33469685
<sup>68</sup>Ga-FAPI outperforms <sup>18</sup>F-FDG PET/CT in identifying solitary fibrous tumor.
Eur J Nucl Med Mol Imaging
2021
32372565
Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA-seq analysis with RT-qPCR validation.
Cancer Med
2020
33532584
Resection and survival data from a clinical trial of glioblastoma multiforme-specific IRDye800-BBN fluorescence-guided surgery.
Bioeng Transl Med
2020
32080121
The maximum standardized uptake value and extent of peritoneal involvement may predict the prognosis of patients with recurrent ovarian cancer after primary treatment: A retrospective clinical study.
Medicine (Baltimore)
2020
31832728
Dose escalation of an Evans blue-modified radiolabeled somatostatin analog <sup>177</sup>Lu-DOTA-EB-TATE in the treatment of metastatic neuroendocrine tumors.
Eur J Nucl Med Mol Imaging
2020
32096786
Time-effect of penile color duplex Doppler ultrasound for diagnosing vascular erectile dysfunction.
Med Ultrason
2020
31977483
Increased FDG Uptake on Juxtaglomerular Cell Tumor in the Left Kidney Mimicking Malignancy.
Clin Nucl Med
2020
32104227
Systematic prediction of the biological functions of TAS2R10 using positive co-expression analysis.
Exp Ther Med
2020
31880916
Combined <sup>68</sup>Ga-NOTA-Evans Blue Lymphoscintigraphy and <sup>68</sup>Ga-NOTA-RM26 PET/CT Evaluation of Sentinel Lymph Node Metastasis in Breast Cancer Patients.
Bioconjug Chem
2020
33193439
Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging.
Front Immunol
2020
32910043
FDG PET/CT Findings in a Patient With Ovarian Metastasis of Pheochromocytoma.
Clin Nucl Med
2020
32732920
The value of multiparameter <sup>18</sup>F-FDG PET/CT imaging in differentiating retroperitoneal paragangliomas from unicentric Castleman disease.
Sci Rep
2020
32332317
Primary Pancreatic Yolk Sac Tumor Presenting as Diffusely Enlarged Pancreas in Initial 18F-FDG PET/CT.
Clin Nucl Med
2020
32358086
<sup>177</sup>Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate Cancer.
J Nucl Med
2020
1 - 50 of 190
Column Actions
Search
Recommended Authors
Randy Yeh
Department of Radiology Memorial Sloan Kettering Cancer Center
Career Start Year
2017
Number of shared co-authors
0
Samira M Sadowski
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2012
Number of shared co-authors
0
Pedram Heidari
Massachusetts General Hospital
Career Start Year
2008
Number of shared co-authors
2
Spencer C Behr
University of California san francisco
Career Start Year
2007
Number of shared co-authors
2
Thomas A Hope
University of California san francisco
Career Start Year
2007
Number of shared co-authors
2
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year
2005
Number of shared co-authors
0
Guido Davidzon
Stanford University
Career Start Year
2005
Number of shared co-authors
0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year
2004
Number of shared co-authors
1
Lin Qi
Xiangya Hospital of Central South University
Career Start Year
2003
Number of shared co-authors
0
Yen-Lin Chen
34903Fu-Jen Catholic University
Career Start Year
2001
Number of shared co-authors
1
Ji Young Lee
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year
2000
Number of shared co-authors
0
Chuong Bui
Nepean Hospital
Career Start Year
1999
Number of shared co-authors
0
Jeong-Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
1999
Number of shared co-authors
0
Irina Rachinsky
University of Western Ontario
Career Start Year
1999
Number of shared co-authors
0
Woo Young Kim
Westchester Medical Center
Career Start Year
1998
Number of shared co-authors
0
Nobuyuki Kosaka
University of Fukui.
Career Start Year
1997
Number of shared co-authors
0
Winnie Wing-Chuen Lam
Singapore General Hospital
Career Start Year
1997
Number of shared co-authors
0
Neeta Pandit-Taskar
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
2
Jun Matsubayashi
Tokyo Medical University
Career Start Year
1996
Number of shared co-authors
0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year
1996
Number of shared co-authors
0
Jung-Il Lee
Gangnam Severance Hospital
Career Start Year
1995
Number of shared co-authors
0
Jong Hoon Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
1995
Number of shared co-authors
3
Dong Wook Kim
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Career Start Year
1992
Number of shared co-authors
0
Dhaval Patel
National Cancer Institute, National Institutes of Health
Career Start Year
1991
Number of shared co-authors
0
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Career Start Year
1991
Number of shared co-authors
0
Johannes Czernin
university of california los angeles
Career Start Year
1987
Number of shared co-authors
2
Richard L Wahl
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Career Start Year
1983
Number of shared co-authors
1
Peter L Choyke
National Cancer Institute, National Institutes of Health
Career Start Year
1982
Number of shared co-authors
2
Daniel Picard
Groupe Hospitalier Universitaire Pitie-Salpetriere
Career Start Year
1981
Number of shared co-authors
0
Peter S Conti
Keck School of Medicine of USC
Career Start Year
1971
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Xiaoyuan Chen
Institute of Molecular and Cell Biology
Co-authored papers
27
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Co-authored papers
15
Chenxi Wu
College of Clinical Medicine, Jining Medical University
Co-authored papers
14
Lixin Lang
First Hospital of Shanxi Medical University, Shanxi Medical University
Co-authored papers
13
Rong Fan
Institute of Pathogens and Vectors, Dali University
Co-authored papers
8
Kun Zheng
Institute of Chemistry, Chinese Academy of Sciences
Co-authored papers
8
Dale O Kiesewetter
National Institute of Biomedical Imaging and Bioengineering
Co-authored papers
3
Qianqian Han
Co-authored papers
3
Miao Yu
Co-authored papers
2
Hai-Feng Pan
Co-authored papers
1
Xinping Tian
Peking Union Medical College Hospital (PUMCH)
Co-authored papers
1
Zhifang Wu
The First Hospital of Shanxi Medical University
Co-authored papers
1
Quanzheng Li
Massachusetts General Hospital
Co-authored papers
1
Jiahe Tian
First Medical Center of Chinese PLA General Hospital
Co-authored papers
1
Simon R Cherry
University of California Davis Davis
Co-authored papers
1
Jianan Cui
College of Optical Science and Engineering, Zhejiang University
Co-authored papers
1
Yuan-Chuan Tai
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Co-authored papers
1
Li-Ping Fu
Peking University
Co-authored papers
1
Georg Widhalm
Medical University of Vienna
Co-authored papers
1
Kuang Gong
University of Florida
Co-authored papers
1
Ning Guo
Beijing Tongren Hospital, Capital Medical University
Co-authored papers
1
Huafeng Liu
College of Optical Science and Engineering, Zhejiang University
Co-authored papers
1
Baixuan Xu
First Medical Center, Chinese PLA General Hospital
Co-authored papers
1
Mark M Souweidane
New York Presbyterian and Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Emmanuele A Jannini
Co-authored papers
1
Kyungsang Kim
Massachusetts General Hospital
Co-authored papers
1
Xiaxia Meng
Center for Advanced Medical Computing and Analysis, Massachusetts General Hospital
Co-authored papers
1
Ke Wei
Co-authored papers
1
Christine Marosi
Medical University of Vienna
Co-authored papers
1
1 - 29